Zenotech Laboratories Stock Plummets to New 52-Week Low at Rs. 48.5

Zenotech Laboratories has reached a new 52-week low, hitting Rs. 48.5 today, marking a significant decline in its stock performance. This microcap company in the Pharmaceuticals & Biotechnology sector has been on a downward trend, underperforming its sector by 3.87% today alone. Over the past four days, Zenotech has experienced a consecutive fall, resulting in a total decline of 4.23%.
The stock's performance is further highlighted by its trading position below key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. In stark contrast, the broader market, represented by the Sensex, is experiencing a positive trend, having reached a new 52-week high of 84,343.83 today.

Zenotech's one-year performance reflects a substantial decline of 46.79%, while the Sensex has gained 3.85% over the same period. The company's financial metrics indicate challenges, with net sales growth at an annual rate of just 12.32% over the last five years and a significant drop in profits. As the stock continues to navigate these difficulties, its recent low underscores the ongoing struggles within the company.